Table 2.
Protein | Epitope | Size (aa) | Position | Nº of alleles1 | % of total alleles2 | Immunogenicity (Percentile Rank)3 | Nº of HLAs w/Percentile Rank < 204 | Nº of HLAs w/ SMM align IC50 < 500 nM5 | Nº of HLAs w/NN align IC50 < 500nM6 | IFNepitope Score (SVM)7 |
---|---|---|---|---|---|---|---|---|---|---|
Capsid Protein | HGPIRMVLAILAFLR (C_41-55) | 15 | 41–55 | 37 | 72.54 | 24.3268 | 21 | 17 | 14 | 0.4521 |
prM Protein | TTSTWVVYGTCHHKK (prM_71-85) | 15 | 71–85 | 31 | 60.8 | 65.45964 | 4 | 0 | 2 | − 0.1269 |
Envelope Protein E | EYRIMLSVHGSQHSG (E_136-150) | 15 | 136–150 | 33 | 64.7 | 40.45516 | 13 | 9 | 12 | − 0.1841 |
Envelope Protein E | DKLRLKGVSYSLCTA (E_296-310) | 15 | 296–310 | 34 | 66.6 | 46.33096 | 12 | 2 | 12 | − 0.3609 |
NS1 | SYFVRAAKTNNSFVV (NS1_121-135) | 15 | 121–135 | 30 | 58.8 | 31.18672 | 11 | 12 | 12 | 0.3363 |
NS2A | PFVMALGLTAVRLVD (NS2A_196-210) | 15 | 196–210 | 29 | 56.8 | 42.90484 | 17 | 11 | 14 | 0.2505 |
NS2B | FAAGAWYVYVKTGKR (NS2B_116-130) | 15 | 116–130 | 11 | 27.50 | 42.51056 | 14 | 5 | 9 | 0.5012 |
NS3 | LRGLPVRYMTTAVNV (NS3_236-250) | 15 | 236–250 | 35 | 68.6 | 43.8254 | 12 | 8 | 13 | 0.4513 |
NS4A | LGIFFVLMRNKGIGK (NS4A_66-80) | 15 | 66–80 | 40 | 78.4 | 25.47468 | 21 | 10 | 14 | 0.0979 |
NS4B | HYMYLIPGLQAAAAR (NS4B_119-133) | 15 | 119–133 | 18 | 35.29 | 42.61168 | 19 | 10 | 14 | 0.0579 |
NS4B | VAVSSAILSRTAWGW (NS4B_178-192) | 15 | 178–192 | 38 | 74.5 | 49.2798 | 13 | 6 | 6 | 0.3106 |
NS5 | LLYFHRRDLRLMANA (NS5_766-780) | 15 | 766–780 | 36 | 70.6 | 38.39304 | 20 | 8 | 12 | 0.2457 |
1—Total number of HLA-II covered by the peptide as predicted by Propred MHC-II Binding Peptide Predicition Server. All 51 alleles were selected. The threshold was set up as 1%.
2—Percentage of HLA-II molecules identified as binders in relation to the total number of HLA-II available.
3—Immunogenicity percentile rank obtained with http://tools.iedb.org/CD4episcore/. Lower numbers are considered immunogenic (lower than 66).
4—Number of HLA that presented percentile rank lower than 20 (high affinity).
5—Number of HLA that presented SMM IC50 lower than 500 nM (high affinity).
6—Number of HLA that presented NN IC50 lower than 500 nM (high affinity).
7—IFN-γ induction score. Positive values indicate IFN-γ induction.